Stocks · Health care · Biological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG

CRSP Clue Score37

Switzerland Fiscal year ends December CIK 0001674416 Results filed 2 Nov 2026

Add to watchlist

By person

9 insiders · 30 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Samarth Kulkarni

Chief Executive Officer

—

$9.60M (9) scheduled

−$9.60M

311,899

0.3226%

$15.53M

−0.1%

Raju Prasad

Chief Financial Officer

—

$5.10M (10) scheduled

−$5.10M

14,815

0.0153%

$737.49K

+128.8%

James R. Kasinger

General Counsel and Secretary

—

$1.37M (7) scheduled

−$1.37M

95,857

0.0991%

$4.77M

+50.5%

Ali Behbahani

Director

—

$780.94K (1) scheduled

−$780.94K

16,695

0.0173%

$831.08K

+5,484%

Simeon George

Director

—

$720.37K (1) scheduled

−$720.37K

3,784,428

3.91%

$188.39M

+36.2%

Naimish Patel

Chief Medical Officer

—

$362.60K (2)

−$362.60K

19,357

0.0200%

$963.59K

+3,170%

Douglas A Treco

Director

—

22,000

0.0228%

$1.10M

+1,000%

Julianne Bruno

Chief Operating Officer

—

10,544

0.0109%

$524.88K

+56.3%

John Greene

Director

—

7,000

0.0072%

$348.46K

—

CRISPR Therapeutics AG

What the insiders did Net selling

By person